The Anticancer Effect of Napabucasin (BBI608), a Natural Naphthoquinone

The Anticancer Effect of Napabucasin (BBI608), a Natural Naphthoquinone

Napabucasin (also known as BBI608) is a natural naphthoquinone originally identified as a cancer cell stemness inhibitor. Accumulated in vitro and in vivo evidence demonstrated that napabucasin showed significant anticancer effects in various types of cancers. Napabucasin inhibits cancer cell prolif...

Full description

Bibliographic Details
Main Authors:	Zeyang Shao, Heng Wang, Haiyan Ren, Yinxiang Sun, Xiuping Chen
Format:	Article
Language:	English
Published:	MDPI AG 2023-07-01
Series:	Molecules
Subjects:	napabucasin cancer STAT3 NQO1
Online Access:	https://www.mdpi.com/1420-3049/28/15/5678

Similar Items

Napabucasin Induces Mouse Bone Loss by Impairing Bone Formation via STAT3
by: Xiangru Huang, et al.
Published: (2021-03-01)

Effects of a reactive oxygen species generator, napabucasin (BBI608), on tolerability, safety, pharmacokinetics, and QT/QTc interval in healthy volunteers
by: Naoto Noda, et al.
Published: (2021-10-01)

The Cancer Stem Cell Inhibitor Napabucasin (BBI608) Shows General Cytotoxicity in Biliary Tract Cancer Cells and Reduces Cancer Stem Cell Characteristics
by: Marlena Beyreis, et al.
Published: (2019-02-01)

Molecular crosstalk between MUC1 and STAT3 influences the anti-proliferative effect of Napabucasin in epithelial cancers
by: Mukulika Bose, et al.
Published: (2024-02-01)

Napabucasin Reduces Cancer Stem Cell Characteristics in Hepatocellular Carcinoma
by: Ya Li, et al.
Published: (2020-12-01)

Inhibitory effect of napabucasin on arbidol metabolism and its mechanism research
by: Jingjing Nie, et al.
Published: (2023-11-01)

Apoptotic tumor cell-derived microparticles loading Napabucasin inhibit CSCs and synergistic immune therapy
by: Boping Jing, et al.
Published: (2023-02-01)

Novel mechanism of napabucasin, a naturally derived furanonaphthoquinone: apoptosis and autophagy induction in lung cancer cells through direct targeting on Akt/mTOR proteins
by: Korrakod Petsri, et al.
Published: (2022-09-01)

Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trialResearch in context
by: Tanios Bekaii-Saab, et al.
Published: (2023-04-01)

Napabucasin, a novel STAT3 inhibitor suppresses proliferation, invasion and stemness of glioblastoma cells
by: Dongfeng Han, et al.
Published: (2019-07-01)

Therapeutic Targeting Strategies of Cancer Stem Cells in Gastrointestinal Malignancies
by: Mohamad B. Sonbol, et al.
Published: (2019-03-01)

5-Methoxytryptophan Sensitizing Head and Neck Squamous Carcinoma Cell to Cisplatitn Through Inhibiting Signal Transducer and Activator of Transcription 3 (STAT3)
by: Yu-Chieh Su, et al.
Published: (2022-07-01)

Inhibition of STAT3 blocks protein synthesis and tumor metastasis in osteosarcoma cells
by: Dongqing Zuo, et al.
Published: (2018-10-01)

Ipilimumab, Pembrolizumab, or Nivolumab in Combination with BBI608 in Patients with Advanced Cancers Treated at MD Anderson Cancer Center
by: Henry Hiep Vo, et al.
Published: (2022-03-01)

LncRNA Nqo1-AS1 Attenuates Cigarette Smoke-Induced Oxidative Stress by Upregulating its Natural Antisense Transcript Nqo1
by: Haiyun Zhang, et al.
Published: (2021-09-01)

Virtual Screening for Potential Phytobioactives as Therapeutic Leads to Inhibit NQO1 for Selective Anticancer Therapy
by: Bhargav Shreevatsa, et al.
Published: (2021-11-01)

Searching for Frataxin Function: Exploring the Analogy with Nqo15, the Frataxin-like Protein of Respiratory Complex I from <i>Thermus thermophilus</i>
by: Davide Doni, et al.
Published: (2024-02-01)

Expressão de galectina-3 e beta-catenina em lesões pré-malignas e carcinomatosas de língua de camundongos Galectin-3 and beta-catenin expression in premalignant and carcinomatous lesions in tongue of mice
by: Juliana Moreira de Almeida Sant'ana, et al.
Published: (2011-02-01)

Role of STAT3 in the pathogenesis of nasopharyngeal carcinoma and its significance in anticancer therapy
by: Yishimei Si, et al.
Published: (2022-10-01)

Discovery of Isoplumbagin as a Novel NQO1 Substrate and Anti-Cancer Quinone
by: Yen-Chi Tsao, et al.
Published: (2020-06-01)

NQO1 Enzyme and its Role in Cellular Protection; an Insight
by: Ahmed Atia, et al.
Published: (2020-06-01)

Cancer Cell Sensitivity to Redox-Cycling Quinones is Influenced by NAD(P)H: Quinone Oxidoreductase 1 Polymorphism
by: Christophe Glorieux, et al.
Published: (2019-09-01)

Ozone-Induced Lung and Bronchial Injury: A Mouse Model Study
by: Shi Liang, et al.
Published: (2022-09-01)

Kenya and the BBI Five
by: Makau Mutua

NQO1 potentiates apoptosis evasion and upregulates XIAP via inhibiting proteasome-mediated degradation SIRT6 in hepatocellular carcinoma
by: Hong-Zhong Zhou, et al.
Published: (2019-12-01)

Pan-cancer and single-cell analysis reveal the prognostic value and immune response of NQO1
by: Liping Shen, et al.
Published: (2023-07-01)

Methylmercury (MeHg) transcriptionally regulates NAD(P)H:quinone oxidoreductase 1 (NQO1) in Hepa-1c1c7 cells
by: Mohammed A. Alqahtani, et al.
Published: (2023-01-01)

NQO1 Deficiency Aggravates Renal Injury by Dysregulating Vps34/ATG14L Complex during Autophagy Initiation in Diabetic Nephropathy
by: Geum-Lan Hong, et al.
Published: (2021-02-01)

Squamous cell carcinoma of the tongue in Sprague-Dawley rats using 4-nitroquinoline 1-oxide model
by: Erni Erfan, et al.
Published: (2016-03-01)

SIRT3 deficiency exacerbates fatty liver by attenuating the HIF1α-LIPIN 1 pathway and increasing CD36 through Nrf2
by: Emma Barroso, et al.
Published: (2020-09-01)

Natural Compounds, Optimal Combination of Brusatol and Polydatin Promote Anti-Tumor Effect in Breast Cancer by Targeting Nrf2 Signaling Pathway
by: Jing Li, et al.
Published: (2023-05-01)

The BBI Judgment and the Invention of Kenya
by: Ambreena Manji

The Multifaced Role of STAT3 in Cancer and Its Implication for Anticancer Therapy
by: Manlio Tolomeo, et al.
Published: (2021-01-01)

The direct STAT3 inhibitor 6-ethoxydihydrosanguinarine exhibits anticancer activity in gastric cancer
by: Xuewen Liu, et al.
Published: (2022-10-01)

Heterocyclic Iminoquinones and Quinones from the National Cancer Institute (NCI, USA) COMPARE Analysis
by: Naemah Haji, et al.
Published: (2023-07-01)

Silymarin Alleviates Oxidative Stress and Inflammation Induced by UV and Air Pollution in Human Epidermis and Activates β-Endorphin Release through Cannabinoid Receptor Type 2
by: Cloé Boira, et al.
Published: (2024-02-01)

Trimethyl Lock Quinone-Based Organic Molecular Probes for NQO1 Sensing and Imaging
by: Kun Chen, et al.
Published: (2023-04-01)

Neuroprotective Properties of Quinone Reductase 2 Inhibitor M-11, a 2-Mercaptobenzimidazole Derivative
by: Mikhail V. Voronin, et al.
Published: (2021-12-01)

New Statement about NRF2 in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
by: Isabel Lastres-Becker, et al.
Published: (2022-08-01)

Redox state and the sirtuin deacetylases are major factors that regulate the acetylation status of the stress protein NQO1
by: David Siegel, et al.
Published: (2022-11-01)